2026 Q1 Portfolio Activity
In 2026 Q1, Lunate Capital Ltd maintained a portfolio of 6 distinct positions. The fund also reduced its exposure to REVOLUTION MEDICINES INC by 75.0%.
Position History
hover any row below to update
Loading…
Lunate Capital Ltd
AUM $120M
Total Positions
6
Quarter
2026 Q1
Top Holding
RVMD (44.4%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-6 of 6
Lunate Capital Ltd Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 44.36% | 66.20% |
#1
Prev: #1
|
6.0 |
—
|
-1,647,150 | -75.0% |
P
S
|
549,050 | $53,395,113 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-04-16 | |||
|
SAIL
SAILPOINT INC
|
Technology | 33.00% | 22.97% |
#2
Prev: #2
|
6.5 |
—
|
no change | no change |
P
S
|
3,000,000 | $39,720,000 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-04-16 | |||
|
LINE
LINEAGE INC
|
Real Estate | 16.33% | 7.95% |
#3
Prev: #3
|
6.0 |
—
|
no change | no change |
P
S
|
600,000 | $19,656,000 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-04-16 | |||
|
NMRA
NEUMORA THERAPE...
|
Healthcare | 3.44% | 1.44% |
#4
Prev: #4
|
2.9 |
—
|
no change | no change |
P
S
|
2,124,143 | $4,142,079 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-04-16 | |||
|
NAVN
NAVAN INC
|
Technology | 2.20% | 1.29% |
#5
Prev: #5
|
2.4 |
—
|
no change | no change |
P
S
|
200,000 | $2,648,000 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-04-16 | |||
|
RVMDW
REVOLUTION MEDI...
|
Unknown | 0.67% | 0.16% |
#6
Prev: #6
|
1.3 |
—
|
no change | no change |
P
S
|
450,000 | $805,500 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-04-16 |
Showing 1-6 of 6 holdings